Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,176

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,176 results for “ulcerative colitis”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov study NCT02536404. IPD Sharing: NO. Countries: 21. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov study NCT04090411. IPD Sharing: YES. Countries: 23. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Low Dose IL-2 for Ulcerative Colitis

ClinicalTrials.gov study NCT02200445. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

ClinicalTrials.gov study NCT00619489. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

ClinicalTrials.gov study NCT05668013. IPD Sharing: YES. Countries: 16. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

ClinicalTrials.gov study NCT02100696. IPD Sharing: Not stated. Countries: 24. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov study NCT02958865. IPD Sharing: YES. Countries: 19. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

ClinicalTrials.gov study NCT04004611. IPD Sharing: YES. Countries: 5. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis

ClinicalTrials.gov study NCT02921555. IPD Sharing: NO. Countries: 1. Publications: 16.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF

ClinicalTrials.gov study NCT02171429. IPD Sharing: Not stated. Countries: 19. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis

ClinicalTrials.gov study NCT01953354. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

ClinicalTrials.gov study NCT03998488. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

ClinicalTrials.gov study NCT00326209. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

ClinicalTrials.gov study NCT03893565. IPD Sharing: YES. Countries: 15. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

ClinicalTrials.gov study NCT04706793. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

ClinicalTrials.gov study NCT01532648. IPD Sharing: Not stated. Countries: 11. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov study NCT00487539. IPD Sharing: Not stated. Countries: 25. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

ClinicalTrials.gov study NCT03675477. IPD Sharing: NO. Countries: 5. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial

ClinicalTrials.gov study NCT00553163. IPD Sharing: NO. Countries: 1. Publications: 38.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov study NCT03398148. IPD Sharing: YES. Countries: 44. Publications: 4.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record